The most effective molecule is the one that actually arrives.

GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper. Identified in 1973 by Dr. Loren Pickart, it was the key factor found to restore aging liver cells to youthful patterns of protein synthesis. It has since become one of the most studied signaling molecules in longevity and skin health research.

The data is clear: GHK-Cu levels peak at ~200ng/mL in your twenties, then drop by roughly 60% by age sixty. This decline isn’t a coincidence. It’s a direct correlate to the body’s diminishing capacity to maintain skin density and structural resilience.

In longevity science, GHK-Cu is studied as a multi-pathway signaling molecule. Peer-reviewed research has explored its ability to reset the appearance of skin health, support antioxidant defense, and influence the expression of over 4,000 genes toward a more resilient state. We aren’t just applying a serum; we are reintroducing the signal.

The skin’s outer layer, the stratum corneum, is a high-density lipid barrier designed to exclude foreign substances. Passive absorption requires a molecule to be small and oil-soluble. GHK-Cu is neither. With a partition coefficient between -0.94 and -2.24, the molecule is naturally repelled by the skin’s lipid matrix.

GHK-Cu also carries a positive ionic charge. This results in “ionic trapping,” where the peptide binds to negatively charged sites in the dead upper layers and stalls before reaching the deeper layers where its effects have been most studied. Without a protective carrier, the peptide simply accumulates on the surface and degrades.

The data on standard topicals is stark: research shows that while a fraction of a dose may enter the surface, as little as 0.006% may actually reach the skin’s structural foundations. This isn’t a formulation flaw that “higher concentrations” can fix. It’s a fundamental physics problem that most copper peptide products choose to ignore.

Rejūv utilizes a lipid-based liposomal delivery system: nanometric vesicles with a phospholipid exterior that mirrors the structure of cell membranes. Because the carrier is lipophilic, it partitions into the skin’s lipid matrix rather than being repelled by it. The GHK-Cu is encapsulated and shielded from the surface-level environment.

This bilayer protects the peptide from surface-level degradation, ensuring the molecule remains intact. Once the carrier reaches the targeted layers, it releases the GHK-Cu: active and intact, exactly where fifty years of research suggests it can be most effective.

The molecule is unchanged. The research behind it is unchanged. What changes is the potential. Because the peptide actually arrives.